Sumoylation: Implications for Neurodegenerative Diseases

被引:51
作者
Anderson, Dina B. [1 ]
Zanella, Camila A. [2 ]
Henley, Jeremy M. [3 ]
Cimarosti, Helena [2 ]
机构
[1] Ipsen Bioinnovat Ltd, Units Quadrant 4 10, Barton Lane, Abingdon OX14 3YS, Oxon, England
[2] Univ Fed Santa Catarina, Dept Pharmacol, Campus Univ Trindade, BR-88040900 Florianopolis, SC, Brazil
[3] Univ Bristol, Sch Biochem, MRC Ctr Synapt Plast, Bristol BS8 1TD, Avon, England
来源
SUMO REGULATION OF CELLULAR PROCESSES, 2ND EDITION | 2017年 / 963卷
基金
英国惠康基金; 英国生物技术与生命科学研究理事会; 英国医学研究理事会;
关键词
Alzheimer's disease; Amyotrophic lateral sclerosis; Ischemia; Neuronal intranuclear inclusion disease; Parkinson's disease; Polyglutamine diseases; Drug targets; INTRANUCLEAR INCLUSION DISEASE; ALPHA-SYNUCLEIN AGGREGATION; FAMILIAL PARKINSONS-DISEASE; MODIFIER SUMO MODIFICATION; A-BETA GENERATION; PROTEIN SUMOYLATION; ENHANCED SUMOYLATION; ALZHEIMERS-DISEASE; ANDROGEN RECEPTOR; MOUSE MODEL;
D O I
10.1007/978-3-319-50044-7_16
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The covalent posttranslational modifications of proteins are critical events in signaling cascades that enable cells to efficiently, rapidly and reversibly respond to extracellular stimuli. This is especially important in the CNS where the processes affecting synaptic communication between neurons are highly complex and very tightly regulated. Sumoylation regulates the function and fate of a diverse array of proteins and participates in the complex cell signaling pathways required for cell survival. One of the most complex signaling pathways is synaptic transmission. Correct synaptic function is critical to the working of the brain and its alteration through synaptic plasticity mediates learning, mental disorders and stroke. The investigation of neuronal sumoylation is a new and exciting field and the functional and pathophysiological implications are far-reaching. Sumoylation has already been implicated in a diverse array of neurological disorders. Here we provide an overview of current literature highlighting recent insights into the role of sumoylation in neurodegeneration. In addition we present a brief assessment of drug discovery in the analogous ubiquitin system and extrapolate on the potential fordevelopment of novel therapies that might target SUMO-associated mechanisms of neurodegenerative disease.
引用
收藏
页码:261 / 281
页数:21
相关论文
共 149 条
  • [21] Fighting polyglutamine disease by wrestling with SUMO
    Craig, Tim J.
    Henley, Jeremy M.
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2015, 125 (02) : 498 - 500
  • [22] SUMO2/3 conjugation is an endogenous neuroprotective mechanism
    Datwyler, Anna Lena
    Laettig-Tuennemann, Gisela
    Yang, Wei
    Paschen, Wulf
    Lee, Sabrina Lin Lin
    Dirnagl, Ulrich
    Endres, Matthias
    Harms, Christoph
    [J]. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2011, 31 (11) : 2152 - 2159
  • [23] SUMO-1 modification of histone deacetylase 1 (HDAC1) modulates its biological activities
    David, G
    Neptune, MA
    DePinho, RA
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (26) : 23658 - 23663
  • [24] Small ubiquitin-like modifier (SUMO) modification of natively unfolded proteins tau and α-synuclein
    Dorval, V
    Fraser, PE
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (15) : 9919 - 9924
  • [25] SUMO on the road to neurodegeneration
    Dorval, Veronique
    Fraser, Paul E.
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2007, 1773 (06): : 694 - 706
  • [26] Modulation of Aβ generation by small ubiquitin-like modifiers does not require conjugation to target proteins
    Dorval, Veronique
    Mazzella, Matthew J.
    Mathews, Paul M.
    Hay, Ronald T.
    Fraser, Paul E.
    [J]. BIOCHEMICAL JOURNAL, 2007, 404 (02) : 309 - 316
  • [27] SUMO and Parkinson's Disease
    Eckermann, Katrin
    [J]. NEUROMOLECULAR MEDICINE, 2013, 15 (04) : 737 - 759
  • [28] Small Changes, Big Impact: Posttranslational Modifications and Function of Huntingtin in Huntington Disease
    Ehrnhoefer, Dagmar E.
    Sutton, Liza
    Hayden, Michael R.
    [J]. NEUROSCIENTIST, 2011, 17 (05) : 475 - 492
  • [29] Fang H, 2011, NEUROENDOCRINOL LETT, V32, P313
  • [30] SUMO-1 modification increases human SOD1 stability and aggregation
    Fei, Erkang
    Jia, Nali
    Yan, Ming
    Ying, Zheng
    Sun, Qiang
    Wang, Hongfeng
    Zhang, Tao
    Ma, Xiaochuan
    Ding, Husheng
    Yao, Xuebiao
    Shi, Yunyu
    Wang, Guanghui
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2006, 347 (02) : 406 - 412